Clinical trial TRM-010
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination with Pembrolizumab or Other Anticancer Treatments in Participants with Advanced Solid Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1/1b |
| Academic trial | Non |
| Sponsor | iTeos |
| EudraCT Identifier | 2024-520369-30-00 |
| Last update |